Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 834 results for "mylan"

Mylan, Momenta in Exclusive Global Biosimilar Alliance
Contract Pharma

Mylan and Momenta to jointly develop and commercialize six bio...

Posted 05/02/2016 Mylan NV has agreed an exclusive global collaboration with Momenta Pharmaceuticals Inc (Momenta) to develop, manufacture and commercialize six of Momenta's biosimilar candidates. Included in the six is a version of ... GaBi Online, 19 hours ago
Mylan and Momenta link up to develop biosimilars Pharma Letter, 3 weeks ago

57 images for mylan

Ticker Report, 2 days ago
WBOY, 2 hours ago
WBOY, 2 hours ago
WBOY, 2 hours ago
WBOY, 2 hours ago
Nasdaq, 1 day ago, 2 days ago
Nasdaq, 2 days ago
ACQ Magazine, 1 week ago, 1 week ago

Human medicines European public assessment report (EPAR): Pregabalin Mylan, pregabalin, Revision: 1, Authorised

This is a summary of the European public assessment report (EPAR) for Pregabalin Mylan. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical ...
 European Medicines Agency1 day ago

Pending EC decision: Amlodipine / Valsartan Mylan , amlodipine / valsartan , Opinion date: 28-Jan-2016

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Amlodipine-Valsartan Mylan, intended for the treatment of essential hypertension.
 European Medicines Agency1 week ago Pending EC decision: Zonisamide Mylan, zonisamide, Opinion date: 28-Jan-2016  European Medicines Agency1 week ago Pending EC decision: Rasagiline Mylan, rasagiline, Opinion date: 28-Jan-2016  European Medicines Agency1 week ago

Wed: TASE downward slide continues

Teva, Mylan and Opko Health led the TASE down today but Delek's energy units bucked the market. The Tel Aviv Stock Exchange (TASE) fell today. The Tel Aviv 25 Index fell 0.64% to 1,448.10 points, the Tel Aviv 100 Index fell 0.71%, to 1,244.17 ...
 Globes2 days ago Sun: Pharmaceutical cos lift TASE  Globes1 week ago Wed: Global market gloom drags down TASE  Globes2 weeks ago Wed: TASE resumes slide  Globes3 weeks ago

The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS Therapeutics announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include theGilead ...
 Yahoo! Finance2 days ago
ACQ Magazine

Mylan Becomes #3 Most Shorted Nasdaq 100 Component, Replacing Tripadvisor

 Forbes.com1 week ago Mylan Takes Over #164 Spot From O'Reilly Automotive  Pettinga Financial Advisors1 week ago David Einhorn's New Long Position In Mylan  Benzinga.com2 weeks ago Einhorn's Greenlight reports new longs in Macy's, E.ON, Mylan  Minyanville2 weeks ago

Epoch's Priest Likes CVS, Black Backs Mylan: Barron's Roundtable

The stock market's January rout may have been painful for investors, but it's opened the door to bargain hunters looking for cheaply valued companies able to weather a global economic slowdown, a panel of money managers told Barron's. A blowup in ...
 Bloomberg6 days ago

Analysts Expect Mylan's Growth to Be at 29.7% for 4Q15

Mylan's 4Q15 Pre-Earnings: A Majority of Brokers Say "Buy" Strong revenue growth in 4Q15 Mylan (MYL) is expected to announce its 4Q15 earnings on February 10, 2016. Analysts are estimating that Mylan's adjusted revenue will be at $2.7 billion for ...
 Yahoo! Finance1 week ago

The Majority of Brokers Recommend a Buy for Mylan

Mylan's 4Q15 Pre-Earnings: A Majority of Brokers Say "Buy" ( Continued from Prior Part ) Analyst recommendations Mylan (MYL) is expected to announce its 4Q15 earnings on February 10, 2016. As of January 22, 2016, Mylan's market cap stood at ...
 Yahoo! Finance1 week ago
Monthly Prescribing Reference

Mylan Launches Generic Felbatol® Tablets

By a News Reporter-Staff News Editor at -- Mylan N.V. ( NASDAQ , TASE: MYL) announced the U.S. launch of Felbamate Tablets USP, 400 mg and 600 mg, which is the generic version of Meda Pharms' Felbatol® Tablets. Mylan received final approval from ...
 Equities.com1 week ago Generic Version of Felbatol Launched  Pharmacy Times1 week ago Mylan to Report Fourth Quarter and Full Year 2015 Financial Results on Feb. 10, 2016  Wall Street Select2 weeks ago Mylan introduces felbamate tablets in US market  PharmaBiz2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less